344 related articles for article (PubMed ID: 23219798)
1. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
King JC; Lichenstein R; Magder LS
Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
[TBL] [Abstract][Full Text] [Related]
2. The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.
Lichenstein R; Magder LS; King RE; King JC
J Infect Dis; 2012 Sep; 206(6):821-7. PubMed ID: 22798684
[TBL] [Abstract][Full Text] [Related]
3. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.
King JC; Lichenstein R; Cummings GE; Magder LS
Vaccine; 2010 Nov; 28(49):7737-42. PubMed ID: 20933566
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
[TBL] [Abstract][Full Text] [Related]
5. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
[TBL] [Abstract][Full Text] [Related]
6. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
8. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
9. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
12. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
13. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B
MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298
[TBL] [Abstract][Full Text] [Related]
14. Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.
Jules A; Grijalva CG; Zhu Y; Talbot HK; Williams JV; Poehling KA; Chaves SS; Edwards KM; Schaffner W; Shay DK; Griffin MR
Pediatrics; 2015 Jan; 135(1):e66-74. PubMed ID: 25489015
[TBL] [Abstract][Full Text] [Related]
15. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
17. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
[TBL] [Abstract][Full Text] [Related]
20. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
